CAMBRIDGE, Mass., February 28, 2013 - OvaScienceSM, (OTC: OVSC), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today announced that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience, will present at the Cowen and Company 33rd Annual Health Care Conference on Wednesday, March 6 at 10:00 a.m. at the Boston Marriott Copley Place in Boston.
A live audio webcast of the presentation can be accessed by visiting the Investor section of the Company's website at www.ovascience.com. A replay of the webcast will be archived on the OvaScience website for two weeks following the presentation.
About OvaScience
OvaScience (OTC: OVSC) is a life sciences company focused on the discovery, development and commercialization of new treatments for infertility. The Company's patented technology is based on the discovery of egg precursor cells (EggPCSM), which are found in the ovaries. By applying proprietary technology to identify and purify EggPCs, AUGMENTSM aims to improve egg quality and increase the success of in vitro fertilization (IVF). OvaScience's team of scientists, physicians and advisers includes recognized leaders in the field of reproductive medicine. For more information, please visit www.ovascience.com.
